Search research articles
Contact Us
Filters
Showing results (51-60 of 105) with videos related to
Page
of 11
Sort By:
Gastroenterology
|
February 1, 1995
Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology
J A Barnard, R D Beauchamp, W E Russell, et al.
The Journal of Clinical Investigation
|
September 1, 1989
Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal
R D Beauchamp, J A Barnard, C M McCutchen, et al.
Annals of Surgical Oncology
|
November 24, 1999
Nonoperative management of primary colorectal cancer in patients with stage IV disease
C R Scoggins, I M Meszoely, C D Blanke, et al.
American Journal of Surgery
|
January 1, 1994
Transforming growth factor-beta inhibits rat intestinal cell growth by regulating cell cycle specific gene expression
T C Ko, R D Beauchamp, C M Townsend, et al.
Gastroenterology
|
June 1, 1993
Insulinlike growth factor-binding protein modulates the growth response to insulinlike growth factor 1 by human gastric cancer cells
Y S Guo, R D Beauchamp, G F Jin, et al.
The Journal of Biological Chemistry
|
August 15, 1998
Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway
H Sheng, C S Williams, J Shao, et al.
Annals of Surgery
|
October 1, 1986
Diagnostic role of gastrointestinal hormones in patients with chronic pancreatitis
W H Nealon, R D Beauchamp, C M Townsend, et al.
Nature Medicine
|
November 14, 1997
Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta
R Chinery, J A Brockman, M O Peeler, et al.
Pancreas
|
September 1, 1994
Lovastatin inhibits pancreatic cancer growth regardless of RAS mutation
S Sumi, R D Beauchamp, C M Townsend, et al.
Cancer Research
|
June 11, 1998
Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells
R Chinery, R D Beauchamp, Y Shyr, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 105) with videos related to
Sort By:
Page
of 11
Gastroenterology
|
February 1, 1995
Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology
J A Barnard, R D Beauchamp, W E Russell, et al.
The Journal of Clinical Investigation
|
September 1, 1989
Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal
R D Beauchamp, J A Barnard, C M McCutchen, et al.
Annals of Surgical Oncology
|
November 24, 1999
Nonoperative management of primary colorectal cancer in patients with stage IV disease
C R Scoggins, I M Meszoely, C D Blanke, et al.
American Journal of Surgery
|
January 1, 1994
Transforming growth factor-beta inhibits rat intestinal cell growth by regulating cell cycle specific gene expression
T C Ko, R D Beauchamp, C M Townsend, et al.
Gastroenterology
|
June 1, 1993
Insulinlike growth factor-binding protein modulates the growth response to insulinlike growth factor 1 by human gastric cancer cells
Y S Guo, R D Beauchamp, G F Jin, et al.
The Journal of Biological Chemistry
|
August 15, 1998
Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway
H Sheng, C S Williams, J Shao, et al.
Annals of Surgery
|
October 1, 1986
Diagnostic role of gastrointestinal hormones in patients with chronic pancreatitis
W H Nealon, R D Beauchamp, C M Townsend, et al.
Nature Medicine
|
November 14, 1997
Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta
R Chinery, J A Brockman, M O Peeler, et al.
Pancreas
|
September 1, 1994
Lovastatin inhibits pancreatic cancer growth regardless of RAS mutation
S Sumi, R D Beauchamp, C M Townsend, et al.
Cancer Research
|
June 11, 1998
Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells
R Chinery, R D Beauchamp, Y Shyr, et al.
Page
of 11